Preparing your results

Our searching services are busy right now. You're search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The role of sphingosine-1-phosphate transporter Spns2 in immune system function.

Sphingosine-1-phosphate (S1P) is lipid messenger involved in the regulation of embryonic development, immune system functions, and many other physiological processes. However, the mechanisms of S1P transport across cellular membranes remain poorly understood, with several ATP-binding cassette family members and the spinster 2 (Spns2) member of the major facilitator superfamily known to mediate S1P transport in cell culture. Spns2 was also shown to control S1P activities in zebrafish in vivo and to play a critical role in zebrafish cardiovascular development. However, the in vivo roles of Spns2 in mammals and its involvement in the different S1P-dependent physiological processes have not been investigated. In this study, we characterized Spns2-null mouse line carrying the Spns2(tm1a(KOMP)Wtsi) allele (Spns2(tm1a)). The Spns2(tm1a/tm1a) animals were viable, indicating a divergence in Spns2 function from its zebrafish ortholog. However, the immunological phenotype of the Spns2(tm1a/tm1a) mice closely mimicked the phenotypes of partial S1P deficiency and impaired S1P-dependent lymphocyte trafficking, with a depletion of lymphocytes in circulation, an increase in mature single-positive T cells in the thymus, and a selective reduction in mature B cells in the spleen and bone marrow. Spns2 activity in the nonhematopoietic cells was critical for normal lymphocyte development and localization. Overall, Spns2(tm1a/tm1a) resulted in impaired humoral immune responses to immunization. This study thus demonstrated a physiological role for Spns2 in mammalian immune system functions but not in cardiovascular development. Other components of the S1P signaling network are investigated as drug targets for immunosuppressive therapy, but the selective action of Spns2 may present an advantage in this regard.

Pubmed ID: 22664872


  • Nijnik A
  • Clare S
  • Hale C
  • Chen J
  • Raisen C
  • Mottram L
  • Lucas M
  • Estabel J
  • Ryder E
  • Adissu H
  • Sanger Mouse Genetics Project
  • Adams NC
  • Ramirez-Solis R
  • White JK
  • Steel KP
  • Dougan G
  • Hancock RE


Journal of immunology (Baltimore, Md. : 1950)

Publication Data

July 1, 2012

Associated Grants

  • Agency: Wellcome Trust, Id: 098051
  • Agency: Wellcome Trust, Id: 098051
  • Agency: Cancer Research UK, Id: 13031
  • Agency: Medical Research Council, Id: G0300212
  • Agency: Medical Research Council, Id: MC_QA137918
  • Agency: Canadian Institutes of Health Research, Id:

Mesh Terms

  • Animals
  • Anion Transport Proteins
  • Cell Differentiation
  • Crosses, Genetic
  • Gene Targeting
  • Immunophenotyping
  • Lymphocyte Subsets
  • Lymphopenia
  • Lysophospholipids
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mutagenesis, Insertional
  • Protein Transport
  • Sphingosine